Company news
Nkarta, Inc. news in 2020
Nkarta, Inc.'s news releases, calls and decks from 2020, newest first.
Nkarta Reports Third Quarter 2020 Financial Results
November 11, 2020
Nkarta Announces Treatment of First Patient in First-in-Human Clinical Trial of Engineered NKG2D-Based NK Cell Cancer Immunotherapy NKX101
November 11, 2020
Nkarta Announces Presentation of Preclinical Data on NKX019, Engineered NK Cell Therapy Candidate Targeting CD19, at the Annual Meeting of the Society for Immunotherapy of Cancer
November 8, 2020
Nkarta Announces November & December 2020 Investor Conference Schedule
November 4, 2020
Nkarta Announces Leadership Changes
October 4, 2020
Nkarta Announces October 2020 Investor Conference Schedule
September 28, 2020
Nkarta Announces September 2020 Virtual Investor Conference Schedule
September 7, 2020
Nkarta Reports Second Quarter 2020 Financial Results
August 19, 2020
Nkarta Announces Closing of Upsized Initial Public Offering and Exercise in Full of Underwriters' Option to Purchase Additional Shares
July 13, 2020
Decks in 2020
- Investor Presentation (November 2020)
Investor deck · 28 slides · November 2020